Publications by Medical Specialty - Cardiology
These publications were authored or co-authored by Quest Diagnostics staff.
- Clinical and Lab healthcare professionals
- Endocrinology, Diabetes & Metabolism
- Family medicine practitioners
- General Health and Wellness
- Geriatrics/Age Management
- Health Information Technology
- Infectious Disease
- Internal Medicine
- Nurse practitioners
- Pathology, Anatomic
- Pathology, Laboratory Medicine
- Physician assistants
- Sports Medicine
- Toxicology/Pain Management
- Women's Health/OB/GYN
'Criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010.
Authors: Pierangeli SS, de Groot PG, Dlott J, Favaloro E, Harris EN, Lakos G, Ortel T, Meroni PL, Otomo K, Pengo V, Tincani A, Wong R, Roubey R.
Testing for variants in CYP2C19: population frequencies and testing experience in a clinical laboratory.
Quest Diagnostics Authors: Strom, C
Authors: Goos D, Crossley B, Zhang K, Buller-Burkle A, Jarvis M, Quan F, Peng M, Sun W.
Genet Med. 2012;14:95-100.
Genetic testing for early detection of individuals at risk of coronary heart disease and monitoring response to therapy: challenges and promises.
Authors: Superko HR, Roberts R, Agatston A, Frohwein S, Reingold JS, White TJ, Sninsky JJ, Margolis B, Momary KM, Garrett BC, King SB, III.
Curr Atheroscler Rep. 2011;13:396-404.
Survival bias and drug interaction can attenuate cross-sectional case-control comparisons of genes with health outcomes. An example of the kinesin-like protein 6 (KIF6) Trp719Arg polymorphism and coronary heart disease.
Authors: Williams P, Pendyala L, Superko R.
BMC Med Genet. 2011;12:42.
The contribution of a 9p21.3 variant, a KIF6 variant, and C-reactive protein to predicting risk of myocardial infarction in a prospective study.
Authors: Shiffman D, O'Meara ES, Rowland CM, Louie JZ, Cushman M, Tracy RP, Devlin JJ, Psaty BM.
BMC Cardiovasc Disord. 2011;11:10.
Change in high-sensitivity c-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individuals.
Authors: Shikuma CM, Ribaudo HJ, Zheng Y, Gulick RM, Meyer WA, Tashima KT, Bastow B, Kuritzkes DR, Glesby MJ.
AIDS Res Hum Retroviruses. 2011;27:461-468.
Authors: Li Y, Luke MM, Shiffman D, Devlin JJ.
Circ Cardiovasc Genet. 2011;4:565-573.
Authors: Luke MM, Berger K, Rowland CM, Catanese JJ, Tong CH, Ross DA, Garcia V, Kuhlenbaeumer G, Ringelstein EB, Pullinger CR, Malloy MJ, Deedwania P, Ellis SG, Kane JP, Devlin JJ, Lalouschek W, Mannhalter C.
Cerebrovasc Dis. 2012;33:80-85.